Orbital Metastases in a Female Patient with Breast Cancer

Breast cancer is the most common malignant disease among women, with a lifetime risk of approximately 10%. Frequent and well-known locations of metastases are bone, liver, lung, skin and brain, but tumour repetition has been seen in almost any anatomic site. Orbital involvement is quite rare, or per...

Full description

Bibliographic Details
Main Authors: G. Fini, F.R. Grippaudo, V. Fenicia, F. Ricotta, P. Virciglio, E. Mici, A. Bozzao, E. Belli
Format: Article
Language:English
Published: SAGE Publishing 2013-05-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/1721727X1301100226
_version_ 1811286728921579520
author G. Fini
F.R. Grippaudo
V. Fenicia
F. Ricotta
P. Virciglio
E. Mici
A. Bozzao
E. Belli
author_facet G. Fini
F.R. Grippaudo
V. Fenicia
F. Ricotta
P. Virciglio
E. Mici
A. Bozzao
E. Belli
author_sort G. Fini
collection DOAJ
description Breast cancer is the most common malignant disease among women, with a lifetime risk of approximately 10%. Frequent and well-known locations of metastases are bone, liver, lung, skin and brain, but tumour repetition has been seen in almost any anatomic site. Orbital involvement is quite rare, or perhaps underestimated. Orbit metastases (OMs) represent 1–13% of all orbital cancers, and are difficult to discriminate with other differential diagnoses, such as a simple blepharitis, or orbital pseudotumor, up to more complex forms of cancer such as lymphoma. The prevalence of OMs is calculated to occur in 2–4.7% of primitive cancer patients. Typical manifestations of orbital metastases include overall regional inflammation, mass effect causing displacement or ocular globe proptosis, pain, bone infiltration, chemosis and eyelid swelling. Infiltration of soft tissue leads to ptosis, diplopia or enophthalmos. We report the case of a 70-year-old female patient who developed chronic inflammatory process of both orbital regions due to orbital metastases, without evidence of other systemic disease after 8 years from primary breast cancer diagnosis. The diagnostic pathway as well as the differential diagnosis are discussed.
first_indexed 2024-04-13T03:06:19Z
format Article
id doaj.art-3ea76c4ac9fe4dbcbfafde76df37ab9a
institution Directory Open Access Journal
issn 1721-727X
language English
last_indexed 2024-04-13T03:06:19Z
publishDate 2013-05-01
publisher SAGE Publishing
record_format Article
series European Journal of Inflammation
spelling doaj.art-3ea76c4ac9fe4dbcbfafde76df37ab9a2022-12-22T03:05:15ZengSAGE PublishingEuropean Journal of Inflammation1721-727X2013-05-011110.1177/1721727X1301100226Orbital Metastases in a Female Patient with Breast CancerG. Fini0F.R. Grippaudo1V. Fenicia2F. Ricotta3P. Virciglio4E. Mici5A. Bozzao6E. Belli7 Maxillo-facial Surgery Unit, NESMOS Department (Neuroscience Mental Health and Sensory Organs), Faculty of Medicine and Psychology, Sapienza University of Rome, Italy Plastic Surgery Unit, NESMOS Department, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy Ophtalmology Unit, NESMOS Department, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy Maxillo-facial Surgery Unit, NESMOS Department (Neuroscience Mental Health and Sensory Organs), Faculty of Medicine and Psychology, Sapienza University of Rome, Italy Maxillo-facial Surgery Unit, NESMOS Department (Neuroscience Mental Health and Sensory Organs), Faculty of Medicine and Psychology, Sapienza University of Rome, Italy Maxillo-facial Surgery Unit, NESMOS Department (Neuroscience Mental Health and Sensory Organs), Faculty of Medicine and Psychology, Sapienza University of Rome, Italy Neuroradiology Unit, NESMOS Department, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy Maxillo-facial Surgery Unit, NESMOS Department (Neuroscience Mental Health and Sensory Organs), Faculty of Medicine and Psychology, Sapienza University of Rome, ItalyBreast cancer is the most common malignant disease among women, with a lifetime risk of approximately 10%. Frequent and well-known locations of metastases are bone, liver, lung, skin and brain, but tumour repetition has been seen in almost any anatomic site. Orbital involvement is quite rare, or perhaps underestimated. Orbit metastases (OMs) represent 1–13% of all orbital cancers, and are difficult to discriminate with other differential diagnoses, such as a simple blepharitis, or orbital pseudotumor, up to more complex forms of cancer such as lymphoma. The prevalence of OMs is calculated to occur in 2–4.7% of primitive cancer patients. Typical manifestations of orbital metastases include overall regional inflammation, mass effect causing displacement or ocular globe proptosis, pain, bone infiltration, chemosis and eyelid swelling. Infiltration of soft tissue leads to ptosis, diplopia or enophthalmos. We report the case of a 70-year-old female patient who developed chronic inflammatory process of both orbital regions due to orbital metastases, without evidence of other systemic disease after 8 years from primary breast cancer diagnosis. The diagnostic pathway as well as the differential diagnosis are discussed.https://doi.org/10.1177/1721727X1301100226
spellingShingle G. Fini
F.R. Grippaudo
V. Fenicia
F. Ricotta
P. Virciglio
E. Mici
A. Bozzao
E. Belli
Orbital Metastases in a Female Patient with Breast Cancer
European Journal of Inflammation
title Orbital Metastases in a Female Patient with Breast Cancer
title_full Orbital Metastases in a Female Patient with Breast Cancer
title_fullStr Orbital Metastases in a Female Patient with Breast Cancer
title_full_unstemmed Orbital Metastases in a Female Patient with Breast Cancer
title_short Orbital Metastases in a Female Patient with Breast Cancer
title_sort orbital metastases in a female patient with breast cancer
url https://doi.org/10.1177/1721727X1301100226
work_keys_str_mv AT gfini orbitalmetastasesinafemalepatientwithbreastcancer
AT frgrippaudo orbitalmetastasesinafemalepatientwithbreastcancer
AT vfenicia orbitalmetastasesinafemalepatientwithbreastcancer
AT fricotta orbitalmetastasesinafemalepatientwithbreastcancer
AT pvirciglio orbitalmetastasesinafemalepatientwithbreastcancer
AT emici orbitalmetastasesinafemalepatientwithbreastcancer
AT abozzao orbitalmetastasesinafemalepatientwithbreastcancer
AT ebelli orbitalmetastasesinafemalepatientwithbreastcancer